Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT06793917 · RECRUITING
Trial details
- NCT number
- NCT06793917
- Sponsor
- Fujian Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-07
- Primary completion
- 2028-04-01
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.